<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="courier ; font-style : italic;} Emerg Infect DisEmerging Infect. DisEIDEmerging" exact="Infectious" post="Diseases1080-60401080-6059Centers for Disease Control and Prevention pmcid: 7323528 pmid:"/>
 <result pre=": italic;} Emerg Infect DisEmerging Infect. DisEIDEmerging Infectious Diseases1080-60401080-6059Centers for" exact="Disease" post="Control and Prevention pmcid: 7323528 pmid: 3256804519-0846 doi: 10.3201/eid2607.190846"/>
 <result pre="Salvador, BA, Brazil; email: guilherme.ribeiro@bahia.fiocruz.br ppub: 2020-726713641373 Abstract After a" exact="chikungunya" post="outbreak in Salvador, Brazil, we performed a cross-sectional, community-based"/>
 <result pre="performed a cross-sectional, community-based study of 1,776 inhabitants to determine" exact="chikungunya" post="virus (CHIKV) seroprevalence, identify factors associated with exposure, and"/>
 <result pre="(CHIKV) seroprevalence, identify factors associated with exposure, and estimate the" exact="symptomatic" post="infection rate. From November 2016 through February 2017, we"/>
 <result pre="seroprevalence, identify factors associated with exposure, and estimate the symptomatic" exact="infection" post="rate. From November 2016 through February 2017, we collected"/>
 <result pre="of seropositive persons reported an episode of fever and arthralgia." exact="Infections" post="were independently and positively associated with residences served by"/>
 <result pre="fever with arthralgia in 2015–2016. Our findings indicate that the" exact="chikungunya" post="outbreak in Salvador may not have conferred sufficient herd"/>
 <result pre="epidemics in the near future. The unusually low frequency of" exact="symptomatic" post="disease points to a need for further longitudinal studies"/>
 <result pre="in the near future. The unusually low frequency of symptomatic" exact="disease" post="points to a need for further longitudinal studies to"/>
 <result pre="further longitudinal studies to better investigate these findings. Keywords: Arboviral" exact="infections" post="asymptomatic infection Brazil chikungunya virus cross-sectional study epidemics epidemiology"/>
 <result pre="studies to better investigate these findings. Keywords: Arboviral infections asymptomatic" exact="infection" post="Brazil chikungunya virus cross-sectional study epidemics epidemiology herd immunity"/>
 <result pre="better investigate these findings. Keywords: Arboviral infections asymptomatic infection Brazil" exact="chikungunya" post="virus cross-sectional study epidemics epidemiology herd immunity outbreaks seroprevalence"/>
 <result pre="cross-sectional study epidemics epidemiology herd immunity outbreaks seroprevalence urban vector-borne" exact="infections" post="viruses In the 21st century, chikungunya virus (CHIKV) has"/>
 <result pre="outbreaks seroprevalence urban vector-borne infections viruses In the 21st century," exact="chikungunya" post="virus (CHIKV) has emerged as a mosquitoborne disease of"/>
 <result pre="21st century, chikungunya virus (CHIKV) has emerged as a mosquitoborne" exact="disease" post="of global relevance, causing large epidemics because of its"/>
 <result pre="tropical and subtropical areas (1). Infected persons usually develop an" exact="acute" post="febrile illness associated with joint pains, myalgia, headache, and"/>
 <result pre="Rico and the US Virgin Islands, the rate at which" exact="CHIKV infection" post="was symptomatic was estimated at &amp;gt;70% (5,6). However, it"/>
 <result pre="and the US Virgin Islands, the rate at which CHIKV" exact="infection" post="was symptomatic was estimated at &amp;gt;70% (5,6). However, it"/>
 <result pre="US Virgin Islands, the rate at which CHIKV infection was" exact="symptomatic" post="was estimated at &amp;gt;70% (5,6). However, it remains unclear"/>
 <result pre="in the Americas; it is unclear whether the proportions of" exact="symptomatic" post="infections differ on the basis of strain type, population,"/>
 <result pre="the Americas; it is unclear whether the proportions of symptomatic" exact="infections" post="differ on the basis of strain type, population, or"/>
 <result pre="Santana, in the northeast state of Bahia, where the East/Central/South" exact="African" post="(ECSA) genotype was detected (7,8). The virus spread rapidly"/>
 <result pre="prevalence of CHIKV IgG as an indicator of all (i.e.," exact="symptomatic" post="and asymptomatic) previous infection in a slum community of"/>
 <result pre="as an indicator of all (i.e., symptomatic and asymptomatic) previous" exact="infection" post="in a slum community of Salvador and assessed the"/>
 <result pre="Salvador and assessed the proportion of cases in which these" exact="infections" post="were symptomatic. In addition, we investigated factors potentially associated"/>
 <result pre="symptomatic. In addition, we investigated factors potentially associated with prior" exact="CHIKV infection." post="Methods Study Site and Participant Selection We performed a"/>
 <result pre="aiming to determine the epidemiology and the transmission dynamics of" exact="leptospirosis" post="(17–19), dengue, and other arboviral diseases (15,16,20,21), as well"/>
 <result pre="other arboviral diseases (15,16,20,21), as well as the burden of" exact="chronic" post="noncommunicable diseases on the community and its residents (22,23)."/>
 <result pre="data on prior presumptive clinical diagnosis of DENV, ZIKV, and" exact="CHIKV infection" post="and on history of fever, arthralgia, myalgia, rash, and"/>
 <result pre="on prior presumptive clinical diagnosis of DENV, ZIKV, and CHIKV" exact="infection" post="and on history of fever, arthralgia, myalgia, rash, and"/>
 <result pre="presence of IgM as a proxy for a more recent" exact="CHIKV infection" post="than if there were no IgM. We interpreted both"/>
 <result pre="of IgM as a proxy for a more recent CHIKV" exact="infection" post="than if there were no IgM. We interpreted both"/>
 <result pre="accuracy of results from the IgG ELISA, we performed a" exact="blind" post="plaque-reduction neutralization test (PRNT) of a stratified random sample"/>
 <result pre="plaque counts (PRNT90), as described elsewhere (25). To investigate whether" exact="cryoglobulinemia" post="could have reduced the sensitivity of the IgG ELISA,"/>
 <result pre="and adjustment for design effect to verify associations between previous" exact="CHIKV infection" post="and the sociodemographic and clinical characteristics of participants. We"/>
 <result pre="adjustment for design effect to verify associations between previous CHIKV" exact="infection" post="and the sociodemographic and clinical characteristics of participants. We"/>
 <result pre="model included only sociodemographic variables to investigate their role in" exact="CHIKV infection," post="whereas the second model included only clinical characteristics to"/>
 <result pre="a positive CHIKV IgG ELISA, we estimated the frequencies of" exact="symptomatic" post="CHIKV infection by calculating the proportion of those who"/>
 <result pre="positive CHIKV IgG ELISA, we estimated the frequencies of symptomatic" exact="CHIKV infection" post="by calculating the proportion of those who reported fever"/>
 <result pre="CHIKV IgG ELISA, we estimated the frequencies of symptomatic CHIKV" exact="infection" post="by calculating the proportion of those who reported fever"/>
 <result pre="fever simultaneously accompanied by arthralgia after January 2015, likely recent" exact="CHIKV infection" post="by calculating the proportion of those with a positive"/>
 <result pre="simultaneously accompanied by arthralgia after January 2015, likely recent CHIKV" exact="infection" post="by calculating the proportion of those with a positive"/>
 <result pre="a positive IgM test result, and presumptive clinical suspicion of" exact="chikungunya" post="by calculating the proportion of those who reported having"/>
 <result pre="used to compare sociodemographic and clinical characteristics between participants with" exact="symptomatic" post="CHIKV infections and those with asymptomatic infections and between"/>
 <result pre="compare sociodemographic and clinical characteristics between participants with symptomatic CHIKV" exact="infections" post="and those with asymptomatic infections and between participants with"/>
 <result pre="between participants with symptomatic CHIKV infections and those with asymptomatic" exact="infections" post="and between participants with likely recent and those with"/>
 <result pre="p &amp;lt;0.01). Of those who consented, a greater proportion were" exact="female" post="(57.0%) than those who did not consent (52.0%; p&amp;lt;0.01)."/>
 <result pre="education (59.0%) or were illiterate (4.3%). Prevalence of Previous CHIKV" exact="Infection" post="and Associated Factors Among the 1,772 (99.8%) participants from"/>
 <result pre="sample, 209 (11.8%, 95% CI 9.8%–13.7%) had had a previous" exact="CHIKV infection," post="as determined by the detection of CHIKV IgG. Of"/>
 <result pre="the 100 IgG-negative samples that we retested to evaluate whether" exact="cryoglobulinemia" post="had reduced ELISA sensitivity, 2 (2%) returned positive results,"/>
 <result pre="(median 3.53, IQR 3.11–3.82). In bivariate analyses, prevalence of previous" exact="CHIKV infection" post="did not differ by sex, skin color, poverty level,"/>
 <result pre="3.53, IQR 3.11–3.82). In bivariate analyses, prevalence of previous CHIKV" exact="infection" post="did not differ by sex, skin color, poverty level,"/>
 <result pre="reported not working (Table 1). Furthermore, the prevalence of previous" exact="CHIKV infection" post="was statistically greater for participants who had received a"/>
 <result pre="not working (Table 1). Furthermore, the prevalence of previous CHIKV" exact="infection" post="was statistically greater for participants who had received a"/>
 <result pre="participants who had received a presumptive clinical diagnosis of an" exact="infection" post="by any of 3 cocirculating arboviruses—CHIKV, DENV, or ZIKV—and"/>
 <result pre="emerged in Salvador (Table 1). Table 1 Prevalence of previous" exact="chikungunya" post="virus infection, determined by detection of IgG, by demographic"/>
 <result pre="in Salvador (Table 1). Table 1 Prevalence of previous chikungunya" exact="virus infection," post="determined by detection of IgG, by demographic and clinical"/>
 <result pre="608 60 (9.0) ≥6 340 5 (13.5) Clinical: reported symptoms†" exact="Fever" post="and arthralgia None 1,212 111 (9.2) &amp;lt;0.01 Only fever"/>
 <result pre="Chikungunya Yes 48 24 (50.0) &amp;lt;0.01 No 1,724 185 (10.7)" exact="Dengue" post="Yes 111 21 (18.9) 0.02 No 1,661 188 (11.3)"/>
 <result pre="after January 2015. The only sociodemographic characteristic associated with previous" exact="CHIKV infection" post="in the multiple variable analyses was residence on an"/>
 <result pre="January 2015. The only sociodemographic characteristic associated with previous CHIKV" exact="infection" post="in the multiple variable analyses was residence on an"/>
 <result pre="1.07–2.15) (Table 2). In addition, independent clinical predictors for previous" exact="CHIKV infection" post="included recall of a presumptive medical diagnosis of chikungunya"/>
 <result pre="(Table 2). In addition, independent clinical predictors for previous CHIKV" exact="infection" post="included recall of a presumptive medical diagnosis of chikungunya"/>
 <result pre="CHIKV infection included recall of a presumptive medical diagnosis of" exact="chikungunya" post="(PR 2.83, 95% CI 1.97–4.05) and report of an"/>
 <result pre="2 Crude and adjusted prevalence ratios for persons with previous" exact="chikungunya" post="virus infection, by demographic and clinical characteristics, Salvador, Brazil,"/>
 <result pre="Crude and adjusted prevalence ratios for persons with previous chikungunya" exact="virus infection," post="by demographic and clinical characteristics, Salvador, Brazil, November 2016–February"/>
 <result pre="(0.92–2.35) Wood/Other material 1.86 (1.06–3.28) Clinical: reported symptoms‡ Model 2" exact="Fever" post="and arthralgia None Referent Referent Only fever 1.29 (0.89–1.86)"/>
 <result pre="2.14 (1.51–3.03) Presumptive clinical diagnosis Chikungunya 4.66 (3.35–6.48) 2.83 (1.97–4.05)" exact="Dengue" post="1.67 (1.09–2.56) Zika 2.45 (1.78–3.39) *Crude prevalence ratios shown"/>
 <result pre="included only sociodemographic variables to investigate potential exposures associated with" exact="CHIKV infection;" post="the second model included only clinical characteristics to investigate"/>
 <result pre=" ‡Reported symptoms with onset after January 2015. Frequency of Symptomatic" exact="Infections" post="among Participants with CHIKV IgG Of the 209 participants"/>
 <result pre="longest duration was 60 days for 1 person. Participants with" exact="symptomatic" post="infection tended to be older (p = 0.07); more"/>
 <result pre="duration was 60 days for 1 person. Participants with symptomatic" exact="infection" post="tended to be older (p = 0.07); more frequently"/>
 <result pre="= 0.07); more frequently reported other clinical manifestations compatible with" exact="CHIKV infection," post="such as myalgia, rash, and pruritus (p&amp;lt;0.01 for each"/>
 <result pre="symptom); and more commonly received a presumptive clinical diagnosis of" exact="chikungunya" post="or Zika (p&amp;lt;0.01 for both) but not of dengue"/>
 <result pre="3 Comparison of sociodemographic and clinical characteristic of participants with" exact="symptomatic" post="versus asymptomatic chikungunya virus infection Salvador, Brazil, November 2016"/>
 <result pre="sociodemographic and clinical characteristic of participants with symptomatic versus asymptomatic" exact="chikungunya" post="virus infection Salvador, Brazil, November 2016 to February 2017*"/>
 <result pre="and clinical characteristic of participants with symptomatic versus asymptomatic chikungunya" exact="virus infection" post="Salvador, Brazil, November 2016 to February 2017* Characteristic Disease"/>
 <result pre="clinical characteristic of participants with symptomatic versus asymptomatic chikungunya virus" exact="infection" post="Salvador, Brazil, November 2016 to February 2017* Characteristic Disease"/>
 <result pre="virus infection Salvador, Brazil, November 2016 to February 2017* Characteristic" exact="Disease" post="status of infected participants, no. %† p value Symptomatic,"/>
 <result pre="(81.8) 0.73 &amp;gt;5.50 5 (15.6) 32 (18.2) Clinical: reported symptoms" exact="Fever" post="and arthralgia None 0 111 (62.7) &amp;lt;0.01 Only fever"/>
 <result pre="20 (62.5) 12 (6.8) &amp;lt;0.01 No 12 (37.5) 165 (93.2)" exact="Dengue" post="Yes 4 (12.5) 17 (9.6) 0.62 No 28 (87.5)"/>
 <result pre="(11.3) &amp;lt;0.01 No 14 (43.7) 157 (88.7%) *NA, not available †CHIKV" exact="disease" post="status was defined as symptomatic on the basis of"/>
 <result pre="157 (88.7%) *NA, not available †CHIKV disease status was defined as" exact="symptomatic" post="on the basis of self-reported fever accompanied by arthralgia"/>
 <result pre="January 2015. ‡Data not available for 1 participant with an asymptomatic" exact="CHIKV infection." post="Frequency of Presumptive Clinical Diagnosis of Chikungunya Among the"/>
 <result pre="Diagnosis of Chikungunya Among the 209 participants with a previous" exact="CHIKV infection," post="24 (11.5%) reported receiving a clinical presumptive diagnosis of"/>
 <result pre="IgG (p&amp;lt;0.01). Noteworthy for the 32 CHIKV-infected participants who had" exact="symptomatic" post="disease, 20 (62.5%) reported a presumptive clinical diagnosis of"/>
 <result pre="symptomatic disease, 20 (62.5%) reported a presumptive clinical diagnosis of" exact="chikungunya" post="(Table 3). On the other hand, of the 48"/>
 <result pre="IgM (data not shown). Discussion Despite retrospective evidence of a" exact="chikungunya" post="outbreak in Salvador during June–November 2015 (12,15), we found"/>
 <result pre="survey had been infected by CHIKV. This seroprevalence is much" exact="lower" post="than that found in 3 additional CHIKV serologic surveys"/>
 <result pre="de Santana, ≈100 km from Salvador, the prevalence of prior" exact="CHIKV infection" post="was estimated at 57.1%; in the urban area of"/>
 <result pre="Santana, ≈100 km from Salvador, the prevalence of prior CHIKV" exact="infection" post="was estimated at 57.1%; in the urban area of"/>
 <result pre="rural area of Riachão do Jacuípe, the prevalence of prior" exact="CHIKV infection" post="was 20.0% in April 2016 (30). It is unlikely"/>
 <result pre="area of Riachão do Jacuípe, the prevalence of prior CHIKV" exact="infection" post="was 20.0% in April 2016 (30). It is unlikely"/>
 <result pre="circulating arboviruses, such as ZIKV and DENV. Furthermore, a very" exact="localized" post="and self-restricted CHIKV outbreak has been recently described in"/>
 <result pre="streets where the houses were located were associated with previous" exact="CHIKV infection," post="pointing to a social gradient that poses an increased"/>
 <result pre="living near sites where water accumulates are associated with increased" exact="chikungunya" post="incidence. The widely accepted understanding of CHIKV infection has"/>
 <result pre="associated with increased chikungunya incidence. The widely accepted understanding of" exact="CHIKV infection" post="has been that the majority (&amp;gt;70%) of infected persons"/>
 <result pre="with increased chikungunya incidence. The widely accepted understanding of CHIKV" exact="infection" post="has been that the majority (&amp;gt;70%) of infected persons"/>
 <result pre="been that the majority (&amp;gt;70%) of infected persons develop a" exact="symptomatic" post="form of the disease (1). We, conversely, found a"/>
 <result pre="(&amp;gt;70%) of infected persons develop a symptomatic form of the" exact="disease" post="(1). We, conversely, found a frequency of symptomatic infection,"/>
 <result pre="of the disease (1). We, conversely, found a frequency of" exact="symptomatic" post="infection, defined by having arthralgia accompanied by fever, of"/>
 <result pre="only 15.3%. Other studies have also found low proportions of" exact="symptomatic" post="CHIKV infection. In Brazil, serologic surveys estimated the proportion"/>
 <result pre="15.3%. Other studies have also found low proportions of symptomatic" exact="CHIKV infection." post="In Brazil, serologic surveys estimated the proportion of symptomatic"/>
 <result pre="CHIKV infection. In Brazil, serologic surveys estimated the proportion of" exact="symptomatic" post="CHIKV infection to be 32.7% in Feira de Santana"/>
 <result pre="infection. In Brazil, serologic surveys estimated the proportion of symptomatic" exact="CHIKV infection" post="to be 32.7% in Feira de Santana and 41.2%"/>
 <result pre="In Brazil, serologic surveys estimated the proportion of symptomatic CHIKV" exact="infection" post="to be 32.7% in Feira de Santana and 41.2%"/>
 <result pre="natural history of disease, have also found low proportions of" exact="symptomatic" post="infections. For example, during a cohort follow-up in the"/>
 <result pre="a cohort follow-up in the Philippines, the subclinical incidence of" exact="CHIKV infection" post="was 10.0 per 100 person-years, while the incidence of"/>
 <result pre="cohort follow-up in the Philippines, the subclinical incidence of CHIKV" exact="infection" post="was 10.0 per 100 person-years, while the incidence of"/>
 <result pre="infection was 10.0 per 100 person-years, while the incidence of" exact="symptomatic" post="CHIKV infection was 2.2 per 100 person-years, indicating that"/>
 <result pre="was 10.0 per 100 person-years, while the incidence of symptomatic" exact="CHIKV infection" post="was 2.2 per 100 person-years, indicating that &amp;lt;20% of"/>
 <result pre="10.0 per 100 person-years, while the incidence of symptomatic CHIKV" exact="infection" post="was 2.2 per 100 person-years, indicating that &amp;lt;20% of"/>
 <result pre="the studies, these findings should be considered limited. Differences in" exact="symptomatic" post="infection rates may be related to the lineage of"/>
 <result pre="studies, these findings should be considered limited. Differences in symptomatic" exact="infection" post="rates may be related to the lineage of CHIKV"/>
 <result pre="persons ≥15 years of age were more likely to have" exact="symptomatic" post="CHIKV infections than others, but the power of our"/>
 <result pre="years of age were more likely to have symptomatic CHIKV" exact="infections" post="than others, but the power of our analyses was"/>
 <result pre="infections than others, but the power of our analyses was" exact="limited" post="by the small number of CHIKV infections that we"/>
 <result pre="our analyses was limited by the small number of CHIKV" exact="infections" post="that we detected. However, our results are in accordance"/>
 <result pre="studies that suggest that women are at increased risk for" exact="symptomatic" post="disease and that risk for symptomatic disease increases with"/>
 <result pre="that suggest that women are at increased risk for symptomatic" exact="disease" post="and that risk for symptomatic disease increases with age"/>
 <result pre="at increased risk for symptomatic disease and that risk for" exact="symptomatic" post="disease increases with age (29). Further cohort studies are"/>
 <result pre="increased risk for symptomatic disease and that risk for symptomatic" exact="disease" post="increases with age (29). Further cohort studies are needed"/>
 <result pre="needed to determine the factors that may influence whether the" exact="infection" post="becomes symptomatic. We also found that chronic arthralgia after"/>
 <result pre="influence whether the infection becomes symptomatic. We also found that" exact="chronic" post="arthralgia after CHIKV infection was uncommon; the maximum reported"/>
 <result pre="infection becomes symptomatic. We also found that chronic arthralgia after" exact="CHIKV infection" post="was uncommon; the maximum reported duration for the articular"/>
 <result pre="becomes symptomatic. We also found that chronic arthralgia after CHIKV" exact="infection" post="was uncommon; the maximum reported duration for the articular"/>
 <result pre="manifestations with less severe arthralgia and low rates of the" exact="disease" post="becoming chronic may occur under certain circumstances of CHIKV"/>
 <result pre="less severe arthralgia and low rates of the disease becoming" exact="chronic" post="may occur under certain circumstances of CHIKV infection. If"/>
 <result pre="the disease becoming chronic may occur under certain circumstances of" exact="CHIKV infection." post="If further investigation supports this hypothesis, this finding might"/>
 <result pre="did find that report of a presumptive clinical diagnosis of" exact="chikungunya" post="disease was strongly associated with having CHIKV IgG (positive"/>
 <result pre="find that report of a presumptive clinical diagnosis of chikungunya" exact="disease" post="was strongly associated with having CHIKV IgG (positive predictive"/>
 <result pre="during and after outbreaks, persons exhibiting CHIKV-associated symptoms and suspected" exact="disease" post="should be clinically tested because of the likelihood of"/>
 <result pre="be clinically tested because of the likelihood of having confirmed" exact="chikungunya" post="disease. Our study findings have limitations. First, we surveyed"/>
 <result pre="ELISA retesting of 100 IgG negative samples, we found that" exact="cryoglobulinemia" post="likely did not influence our seroprevalence; moreover, we found"/>
 <result pre="agreement between the IgG ELISA and the PRNT90. However, because" exact="cryoglobulinemia" post="had been described for CHIKV (45), further surveys should"/>
 <result pre="might not occur or may occur at later stages after" exact="CHIKV infection," post="possibly due to a strong and longlasting CHIKV IgM"/>
 <result pre="that this diagnostic limitation hampered detection of some cases of" exact="CHIKV infection," post="especially those occurring shortly before the survey was conducted."/>
 <result pre="shortly before the survey was conducted. Fourth, the proportion of" exact="symptomatic" post="infections may have been underestimated because of the 2-year"/>
 <result pre="before the survey was conducted. Fourth, the proportion of symptomatic" exact="infections" post="may have been underestimated because of the 2-year gap"/>
 <result pre="have been underestimated because of the 2-year gap between the" exact="chikungunya" post="outbreak in Salvador and when the study was conducted"/>
 <result pre="consider those reporting only fever or only arthralgia to have" exact="symptomatic" post="disease. Thus, the observed symptomatic rate from our study"/>
 <result pre="or only arthralgia to have symptomatic disease. Thus, the observed" exact="symptomatic" post="rate from our study should be considered a minimum"/>
 <result pre="the temporal relation between exposures to risk and occurrence of" exact="CHIKV infection." post="In summary, our findings suggest that although CHIKV and"/>
 <result pre="the population, compared to estimates of 63%–73% for ZIKV (22,48)." exact="Viral" post="competition within hosts and vectors may be a key"/>
 <result pre="Survey used to collect data for study of transmission of" exact="chikungunya" post="virus in an urban slum, Brazil. LINK Suggested citation"/>
 <result pre="Carvalho CX, Portilho MM, Khouri R, et al. Transmission of" exact="chikungunya" post="virus in an urban slum, Brazil. Emerg Infect Dis."/>
 <result pre="management and administrative matters. This study was supported by the" exact="Brazilian" post="National Council for Scientific and Technological Development (grants 400830/2013-2,"/>
 <result pre="G.S.R.); the Coordination for the Improvement of Higher Education Personnel," exact="Brazilian" post="Ministry of Education (grant 88887.130746/2016-00 to G.S.R.); the Research"/>
 <result pre="Science and Technology, Secretariat of Science, Technology and Strategic Inputs," exact="Brazilian" post="Ministry of Health. Ms. Anjos is a nurse with"/>
 <result pre="PhD candidate at the Fundação Oswaldo Cruz, Salvador, Brazil. Her" exact="primary" post="research interests are epidemiology of arboviruses and infectious diseases"/>
 <result pre="Brazil. Her primary research interests are epidemiology of arboviruses and" exact="infectious diseases" post="of global relevance. References References 1. WeaverSC, LecuitM. Chikungunya"/>
 <result pre="and therapy.Antiviral Res. 2013;99:345–70. 10.1016/j.antiviral.2013.06.00923811281 3. FischerM, StaplesJE; collab: Arboviral" exact="Diseases" post="Branch, National Center for Emerging and Zoonotic Infectious Diseases,"/>
 <result pre="collab: Arboviral Diseases Branch, National Center for Emerging and Zoonotic" exact="Infectious" post="Diseases, CDC. Notes from the field: chikungunya virus spreads"/>
 <result pre="Emerging and Zoonotic Infectious Diseases, CDC. Notes from the field:" exact="chikungunya" post="virus spreads in the Americas - Caribbean and South"/>
 <result pre="4. GallianP, Leparc-GoffartI, RichardP, MaireF, FlusinO, DjoudiR, et al.Epidemiology of" exact="chikungunya" post="virus outbreaks in Guadeloupe and Martinique, 2014: an observational"/>
 <result pre="TorresJ, RyffKR, Pérez RodríguezNM, MercadoC, et al.; collab: Centers for" exact="Disease" post="Control and Prevention (CDC). Chikungunya cases identified through passive"/>
 <result pre="6. HennesseyMJ, EllisEM, DeloreyMJ, PanellaAJ, KosoyOI, KirkingHL, et al.Seroprevalence and" exact="symptomatic" post="attack rate of chikungunya virus infection, United States Virgin"/>
 <result pre="PanellaAJ, KosoyOI, KirkingHL, et al.Seroprevalence and symptomatic attack rate of" exact="chikungunya" post="virus infection, United States Virgin Islands, 2014–2015.Am J Trop"/>
 <result pre="KosoyOI, KirkingHL, et al.Seroprevalence and symptomatic attack rate of chikungunya" exact="virus infection," post="United States Virgin Islands, 2014–2015.Am J Trop Med Hyg."/>
 <result pre="10.1186/s12916-015-0348-x25976325 8. TeixeiraMG, AndradeAMS, CostaMC, CastroJN, OliveiraFLS, GoesCSB, et al.East/Central/South" exact="African" post="genotype chikungunya virus, Brazil, 2014.Emerg Infect Dis. 2015;21:906–7. 10.3201/eid2105.14172725898939"/>
 <result pre="TeixeiraMG, AndradeAMS, CostaMC, CastroJN, OliveiraFLS, GoesCSB, et al.East/Central/South African genotype" exact="chikungunya" post="virus, Brazil, 2014.Emerg Infect Dis. 2015;21:906–7. 10.3201/eid2105.14172725898939 9. Secretaria"/>
 <result pre="Vigilância em Saúde/Ministério da Saúde. Monitoring of cases of dengue," exact="chikungunya" post="fever and fever by the Zika virus until epidemiological"/>
 <result pre="Vigilância em Saúde/Ministério da Saúde. Monitoring of cases of dengue," exact="chikungunya" post="fever and fever by the Zika virus until epidemiological"/>
 <result pre="Vigilância em Saúde/Ministério da Saúde. Monitoring of cases of dengue," exact="chikungunya" post="fever and fever by the Zika virus until epidemiological"/>
 <result pre="CardosoCW, KikutiM, PratesAPPB, PaploskiIAD, TauroLB, SilvaMMO, et al.Unrecognized emergence of" exact="chikungunya" post="virus during a Zika virus outbreak in Salvador, Brazil.PLoS"/>
 <result pre="13. de OliveiraWK, CarmoEH, HenriquesCM, CoelhoG, VazquezE, Cortez-EscalanteJ, et al.Zika" exact="virus infection" post="and associated neurologic disorders in Brazil.N Engl J Med."/>
 <result pre="de OliveiraWK, CarmoEH, HenriquesCM, CoelhoG, VazquezE, Cortez-EscalanteJ, et al.Zika virus" exact="infection" post="and associated neurologic disorders in Brazil.N Engl J Med."/>
 <result pre="TauroLB, KikutiM, AnjosRO, SantosVC, GonçalvesTSF, et al.Concomitant transmission of dengue," exact="chikungunya" post="and Zika viruses in Brazil: clinical and epidemiological findings"/>
 <result pre="viruses in Brazil: clinical and epidemiological findings from surveillance for" exact="acute" post="febrile illness.Clin Infect Dis. 2019;69:1353–9. 10.1093/cid/ciy108330561554 16. KikutiM, CunhaGM,"/>
 <result pre="KasperAM, SilvaMM, TavaresAS, et al.Spatial distribution of dengue in a" exact="Brazilian" post="urban slum setting: role of socioeconomic gradient in disease"/>
 <result pre="a Brazilian urban slum setting: role of socioeconomic gradient in" exact="disease" post="risk.PLoS Negl Trop Dis. 2015;9:e0003937. 10.1371/journal.pntd.000393726196686 17. ReisRB, RibeiroGS,"/>
 <result pre="MelendezAXTO, et al.Impact of environment and social gradient on Leptospira" exact="infection" post="in urban slums.PLoS Negl Trop Dis. 2008;2:e228. 10.1371/journal.pntd.000022818431445 18."/>
 <result pre="FelzemburghRDM, RibeiroGS, CostaF, ReisRB, HaganJE, MelendezAXTO, et al.Prospective study of" exact="leptospirosis" post="transmission in an urban slum community: role of poor"/>
 <result pre="MoragaP, CostaF, CapianN, RibeiroGS, WunderEAJr, et al.Spatiotemporal determinants of urban" exact="leptospirosis" post="transmission: four-year prospective cohort study of slum residents in"/>
 <result pre="CostaVBA, et al.; collab: Pau da Lima Urban Health Team." exact="Hypertension" post="in a Brazilian urban slum population.J Urban Health. 2015;92:446–59."/>
 <result pre="collab: Pau da Lima Urban Health Team. Hypertension in a" exact="Brazilian" post="urban slum population.J Urban Health. 2015;92:446–59. 10.1007/s11524-015-9956-125920334 23. SnyderRE,"/>
 <result pre="LimaHCAV, CalcagnoJI, CoutoRD, et al.Differences in the prevalence of non-communicable" exact="disease" post="between slum dwellers and the general population in a"/>
 <result pre="data storage and collection.Spinal Cord. 2018;56:625. 10.1038/s41393-018-0169-929977003 25. BaerA, Kehn-HallK." exact="Viral" post="concentration determination through plaque assays: using traditional and novel"/>
 <result pre="29. DiasJP, CostaMDCN, CamposGS, PaixãoES, NatividadeMS, BarretoFR, et al.Seroprevalence of" exact="chikungunya" post="virus after its emergence in Brazil.Emerg Infect Dis. 2018;24:617–24."/>
 <result pre="CunhaRV, TrintaKS, MontalbanoCA, SucupiraMVF, de LimaMM, MarquesE, et al.Seroprevalence of" exact="chikungunya" post="virus in a rural community in Brazil.PLoS Negl Trop"/>
 <result pre="JeanSE, BullardSM, et al.Use of bead-based serologic assay to evaluate" exact="chikungunya" post="virus epidemic, Haiti.Emerg Infect Dis. 2018;24:995–1001. 10.3201/eid2406.17144729774861 32. TauroLB,"/>
 <result pre="10.3201/eid2406.17144729774861 32. TauroLB, CardosoCW, SouzaRL, NascimentoLC, SantosDRD, CamposGS, et al.A" exact="localized" post="outbreak of Chikungunya virus in Salvador, Bahia, Brazil.Mem Inst"/>
 <result pre="in children and adults in Managua, Nicaragua, after the first" exact="chikungunya" post="epidemic, 2014–2015.PLoS Negl Trop Dis. 2016;10:e0004773. 10.1371/journal.pntd.000477327322692 37. KrystosikAR,"/>
 <result pre="et al.Community context and sub-neighborhood scale detail to explain dengue," exact="chikungunya" post="and Zika patterns in Cali, Colombia.PLoS One. 2017;12:e0181208. 10.1371/journal.pone.018120828767730"/>
 <result pre="AleraMT, LagoCB, Tac-AnIA, VillaD, FernandezS, et al.High rate of subclinical" exact="chikungunya" post="virus infection and association of neutralizing antibody with protection"/>
 <result pre="LagoCB, Tac-AnIA, VillaD, FernandezS, et al.High rate of subclinical chikungunya" exact="virus infection" post="and association of neutralizing antibody with protection in a"/>
 <result pre="Tac-AnIA, VillaD, FernandezS, et al.High rate of subclinical chikungunya virus" exact="infection" post="and association of neutralizing antibody with protection in a"/>
 <result pre="HerZ, TanJJL, LumF-M, LeeWWL, ChanY-H, et al.Caribbean and La Réunion" exact="chikungunya" post="virus isolates differ in their capacity to induce proinflammatory"/>
 <result pre="capacity to induce proinflammatory Th1 and NK cell responses and" exact="acute" post="joint pathology.J Virol. 2015;89:7955–69. 10.1128/JVI.00909-1525995257 40. LangsjoenRM, HallerSL, RoyCJ,"/>
 <result pre="et al.HLA class II allele polymorphism in an outbreak of" exact="chikungunya" post="fever in Middle Andaman, India.Immunology. 2013;140:202–10. 10.1111/imm.1212823710940 42. GordonA,"/>
 <result pre="GreshL, OjedaS, ChowellG, GonzalezK, SanchezN, et al.Differences in transmission and" exact="disease" post="severity between 2 successive waves of chikungunya.Clin Infect Dis."/>
 <result pre="LanciottiR, Leparc-GoffartI. Evaluation of commercially available serologic diagnostic tests for" exact="chikungunya" post="virus.Emerg Infect Dis. 2014;20:2129–32. 10.3201/eid2012.14126925418184 44. De SalazarPM, ValadereAM,"/>
 <result pre="44. De SalazarPM, ValadereAM, GoodmanCH, JohnsonBW. Evaluation of three commercially-available" exact="chikungunya" post="virus immunoglobulin G immunoassays.Rev Panam Salud Publica. 2017;41:e62. 10.26633/RPSP.2017.6228902275"/>
 <result pre="45. OliverM, GrandadamM, MarimoutouC, RogierC, Botelho-NeversE, TolouH, et al.Persisting mixed" exact="cryoglobulinemia" post="in Chikungunya infection.PLoS Negl Trop Dis. 2009;3:e374. 10.1371/journal.pntd.000037419190731 46."/>
 <result pre="CalheirosAS, et al.Differential shedding and antibody kinetics of Zika and" exact="chikungunya" post="viruses, Brazil.Emerg Infect Dis. 2019;25:311–5. 10.3201/eid2502.18016630666934 47. CardosoCW, PaploskiIAD,"/>
</results>
